{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T22:11:52Z","timestamp":1771798312611,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,4,27]],"date-time":"2011-04-27T00:00:00Z","timestamp":1303862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00213-011-2291-7","type":"journal-article","created":{"date-parts":[[2011,4,26]],"date-time":"2011-04-26T07:02:11Z","timestamp":1303801331000},"page":"397-410","source":"Crossref","is-referenced-by-count":27,"title":["Neuroprotection of paliperidone on SH-SY5Y cells against \u03b2-amyloid peptide25-35, N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death"],"prefix":"10.1007","volume":"217","author":[{"given":"Ming-Chang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"For-Wey","family":"Lung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,27]]},"reference":[{"key":"2291_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000202823","volume":"59","author":"BM Al-Chalabi","year":"2009","unstructured":"Al-Chalabi BM, Thanoon IA, Ahmed FA (2009) Potential effect of olanzapine on total antioxidant status and lipid peroxidation in schizophrenic patients. Neuropsychobiology 59:8\u201311","journal-title":"Neuropsychobiology"},{"key":"2291_CR2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jpsychires.2007.10.007","volume":"42","author":"M Alenius","year":"2008","unstructured":"Alenius M, Wadelius M, Dahl ML, Hartvig P, Lindstrom L, Hammarlund-Udenaes M (2008) Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting. J Psychiatr Res 42:884\u2013893","journal-title":"J Psychiatr Res"},{"key":"2291_CR3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0361-9230(86)90181-4","volume":"16","author":"CA Altar","year":"1986","unstructured":"Altar CA, Wasley AM, Neale RF, Stone GA (1986) Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain. Brain Res Bull 16:517\u2013525","journal-title":"Brain Res Bull"},{"key":"2291_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-2999(95)00292-S","volume":"283","author":"J Arnt","year":"1995","unstructured":"Arnt J (1995) Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of d-amphetamine. Eur J Pharmacol 283:55\u201362","journal-title":"Eur J Pharmacol"},{"key":"2291_CR5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.10290","volume":"69","author":"O Bai","year":"2002","unstructured":"Bai O, Wei Z, Lu W, Bowen R, Keegan D, Li X-M (2002) Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal. J Neurosci Res 69:278\u2013283","journal-title":"J Neurosci Res"},{"key":"2291_CR6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jnr.10440","volume":"71","author":"O Bai","year":"2003","unstructured":"Bai O, Chlan-Fourney J, Bowen R, Keegan D, Li XM (2003) Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J Neurosci Res 71:127\u2013131","journal-title":"J Neurosci Res"},{"key":"2291_CR7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2004.02.064","volume":"1010","author":"O Bai","year":"2004","unstructured":"Bai O, Zhang H, Li XM (2004) Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain Res 1010:81\u201386","journal-title":"Brain Res"},{"key":"2291_CR8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00001756-199512000-00085","volume":"7","author":"C Behl","year":"1995","unstructured":"Behl C, Rupprecht R, Skutella T, Holsboer F (1995) Haloperidol-induced cell death\u2014mechanism and protection with vitamin E in vitro. Neuroreport 7:360\u2013364","journal-title":"Neuroreport"},{"key":"2291_CR9","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1080\/15622970903144004","volume":"10","author":"M Bulut","year":"2009","unstructured":"Bulut M, Savas HA, Altindag A, Virit O, Dalkilic A (2009) Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia. World J Biol Psychiatry 10:626\u2013628","journal-title":"World J Biol Psychiatry"},{"key":"2291_CR10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0149-7634(94)90001-9","volume":"18","author":"JL Cadet","year":"1994","unstructured":"Cadet JL, Kahler LA (1994) Free radical mechanisms in schizophrenia and tardive dyskinesia. Neurosci Biobehav Rev 18:457\u2013467","journal-title":"Neurosci Biobehav Rev"},{"key":"2291_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2006.05.023","volume":"86","author":"CJ Carter","year":"2006","unstructured":"Carter CJ (2006) Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability. Schizophr Res 86:1\u201314","journal-title":"Schizophr Res"},{"key":"2291_CR12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0925-4439(97)00070-7","volume":"1362","author":"DS Cassarino","year":"1997","unstructured":"Cassarino DS, Fall CP, Swerdlow RH, Smith TS, Halvorsen EM, Miller SW, Parks JP, Parker WD Jr, Bennett JP Jr (1997) Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim Biophys Acta 1362:77\u201386","journal-title":"Biochim Biophys Acta"},{"key":"2291_CR13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2008.07.021","volume":"1233","author":"P Corena-Mcleod Mdel","year":"2008","unstructured":"Corena-Mcleod Mdel P, Oliveros A, Charlesworth C, Madden B, Liang YQ, Boules M, Shaw A, Williams K, Richelson E (2008) Paliperidone as a mood stabilizer: a pre-frontal cortex synaptoneurosomal proteomics comparison with lithium and valproic acid after chronic treatment reveals similarities in protein expression. Brain Res 1233:8\u201319","journal-title":"Brain Res"},{"key":"2291_CR14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000077368","volume":"49","author":"G Dakhale","year":"2004","unstructured":"Dakhale G, Khanzode S, Khanzode S, Saoji A, Khobragade L, Turankar A (2004) Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics. Neuropsychobiology 49:205\u2013209","journal-title":"Neuropsychobiology"},{"key":"2291_CR15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00213-005-0117-1","volume":"182","author":"GN Dakhale","year":"2005","unstructured":"Dakhale GN, Khanzode SD, Khanzode SS, Saoji A (2005) Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia. Psychopharmacol Berl 182:494\u2013498","journal-title":"Psychopharmacol Berl"},{"key":"2291_CR16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0013-7006(06)76151-6","volume":"32","author":"C Fendri","year":"2006","unstructured":"Fendri C, Mechri A, Khiari G, Othman A, Kerkeni A, Gaha L (2006) Oxidative stress involvement in schizophrenia pathophysiology: a review. Encephale 32:244\u2013252","journal-title":"Encephale"},{"key":"2291_CR17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clinthera.2008.02.011","volume":"30","author":"JA Fowler","year":"2008","unstructured":"Fowler JA, Bettinger TL, Argo TR (2008) Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia. Clin Ther 30:231\u2013248","journal-title":"Clin Ther"},{"key":"2291_CR18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/oxfordjournals.bmb.a011569","volume":"52","author":"S Frangou","year":"1996","unstructured":"Frangou S, Murray RM (1996) Imaging as a tool in exploring the neurodevelopment and genetics of schizophrenia. Br Med Bull 52:587\u2013596","journal-title":"Br Med Bull"},{"key":"2291_CR19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1097-4547(20010301)63:5<421::AID-JNR1037>3.0.CO;2-4","volume":"63","author":"C Gomez","year":"2001","unstructured":"Gomez C, Reiriz J, Pique M, Gil J, Ferrer I, Ambrosio S (2001) Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells. J Neurosci Res 63:421\u2013428","journal-title":"J Neurosci Res"},{"key":"2291_CR20","first-page":"1122","volume":"37","author":"PF Goyer","year":"1996","unstructured":"Goyer PF, Berridge MS, Morris ED, Semple WE, Compton-Toth BA, Schulz SC, Wong DF, Miraldi F, Meltzer HY (1996) PET measurement of neuroreceptor occupancy by typical and atypical neuroleptics. J Nucl Med 37:1122\u20131127","journal-title":"J Nucl Med"},{"key":"2291_CR21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF02245602","volume":"124","author":"BJ Kinon","year":"1996","unstructured":"Kinon BJ, Lieberman JA (1996) Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacol Berl 124:2\u201334","journal-title":"Psychopharmacol Berl"},{"key":"2291_CR22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.biopsych.2004.07.008","volume":"56","author":"M Kodama","year":"2004","unstructured":"Kodama M, Fujioka T, Duman RS (2004) Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry 56:570\u2013580","journal-title":"Biol Psychiatry"},{"key":"2291_CR23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1517\/14656566.7.8.1005","volume":"7","author":"M Krebs","year":"2006","unstructured":"Krebs M, Leopold K, Hinzpeter A, Schaefer M (2006) Current schizophrenia drugs: efficacy and side effects. Expert Opin Pharmacother 7:1005\u20131016","journal-title":"Expert Opin Pharmacother"},{"key":"2291_CR24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/exnr.2000.7460","volume":"165","author":"HS Lee","year":"2000","unstructured":"Lee HS, Park CW, Kim YS (2000) MPP(+) increases the vulnerability to oxidative stress rather than directly mediating oxidative damage in human neuroblastoma cells. Exp Neurol 165:164\u2013171","journal-title":"Exp Neurol"},{"key":"2291_CR25","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0006-3223(01)01303-8","volume":"50","author":"JA Lieberman","year":"2001","unstructured":"Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J (2001) The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry 50:884\u2013897","journal-title":"Biol Psychiatry"},{"key":"2291_CR26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4088\/JCP.v68n0303","volume":"68","author":"JP Lindenmayer","year":"2007","unstructured":"Lindenmayer JP, Khan A, Iskander A, Abad MT, Parker B (2007) A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia. J Clin Psychiatry 68:368\u2013379","journal-title":"J Clin Psychiatry"},{"key":"2291_CR27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2009.05.063","volume":"1283","author":"BC Magliaro","year":"2009","unstructured":"Magliaro BC, Saldanha CJ (2009) Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation. Brain Res 1283:14\u201324","journal-title":"Brain Res"},{"key":"2291_CR28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09540260600581993","volume":"18","author":"SP Mahadik","year":"2006","unstructured":"Mahadik SP, Pillai A, Joshi S, Foster A (2006) Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia. Int Rev Psychiatry 18:119\u2013131","journal-title":"Int Rev Psychiatry"},{"key":"2291_CR29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00001756-200404290-00021","volume":"15","author":"H Miwa","year":"2004","unstructured":"Miwa H, Kubo T, Morita S, Nakanishi I, Kondo T (2004) Oxidative stress and microglial activation in substantia nigra following striatal MPP+. Neuroreport 15:1039\u20131044","journal-title":"Neuroreport"},{"key":"2291_CR30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2009.06.001","volume":"124","author":"R Molteni","year":"2009","unstructured":"Molteni R, Calabrese F, Racagni G, Fumagalli F, Riva MA (2009) Antipsychotic drug actions on gene modulation and signaling mechanisms. Pharmacol Ther 124:74\u201385","journal-title":"Pharmacol Ther"},{"key":"2291_CR31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3109\/15622970802269597","volume":"11","author":"N Mossaheb","year":"2010","unstructured":"Mossaheb N, Spindelegger C, Asenbaum S, Fischer P, Barnas C (2010) Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine. World J Biol Psychiatry 11:502\u2013505","journal-title":"World J Biol Psychiatry"},{"key":"2291_CR32","first-page":"851","volume":"11","author":"F Ng","year":"2008","unstructured":"Ng F, Berk M, Dean O, Bush AI (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11:851\u2013876","journal-title":"Int J Neuropsychopharmacol"},{"key":"2291_CR33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0892-0362(02)00213-1","volume":"24","author":"A Nicotra","year":"2002","unstructured":"Nicotra A, Parvez S (2002) Apoptotic molecules and MPTP-induced cell death. Neurotoxicol Teratol 24:599\u2013605","journal-title":"Neurotoxicol Teratol"},{"key":"2291_CR34","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1046\/j.1471-4159.2000.0752327.x","volume":"75","author":"JS Noh","year":"2000","unstructured":"Noh JS, Kang HJ, Kim EY, Sohn S, Chung YK, Kim SU, Gwag BJ (2000) Haloperidol-induced neuronal apoptosis: role of p38 and c-Jun-NH(2)-terminal protein kinase. J Neurochem 75:2327\u20132334","journal-title":"J Neurochem"},{"key":"2291_CR35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3956(02)00048-1","volume":"37","author":"V Parikh","year":"2003","unstructured":"Parikh V, Khan MM, Mahadik SP (2003) Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 37:43\u201351","journal-title":"J Psychiatr Res"},{"key":"2291_CR36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00004714-200102000-00004","volume":"21","author":"PJ Perry","year":"2001","unstructured":"Perry PJ, Lund BC, Sanger T, Beasley C (2001) Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial. J Clin Psychopharmacol 21:14\u201320","journal-title":"J Clin Psychopharmacol"},{"issue":"684\u201397","key":"2291_CR37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.mp.4001532","volume":"9","author":"S Prabakaran","year":"2004","unstructured":"Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9(684\u201397):643","journal-title":"Mol Psychiatry"},{"key":"2291_CR38","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1046\/j.1460-9568.2003.02590.x","volume":"17","author":"H Qing","year":"2003","unstructured":"Qing H, Xu H, Wei Z, Gibson K, Li X-M (2003) The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis. Eur J Neurosci 17:1563\u20131570","journal-title":"Eur J Neurosci"},{"key":"2291_CR39","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.pnpbp.2009.06.018","volume":"33","author":"M Raffa","year":"2009","unstructured":"Raffa M, Mechri A, Othman LB, Fendri C, Gaha L, Kerkeni A (2009) Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 33:1178\u20131183","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2291_CR40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-9964(02)00407-3","volume":"62","author":"R Reddy","year":"2003","unstructured":"Reddy R, Keshavan M, Yao JK (2003) Reduced plasma antioxidants in first-episode patients with schizophrenia. Schizophr Res 62:205\u2013212","journal-title":"Schizophr Res"},{"key":"2291_CR41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2004.09.032","volume":"372","author":"A Reinke","year":"2004","unstructured":"Reinke A, Martins MR, Lima MS, Moreira JC, Dal-Pizzol F, Quevedo J (2004) Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain. Neurosci Lett 372:157\u2013160","journal-title":"Neurosci Lett"},{"key":"2291_CR42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0920-9964(01)00234-1","volume":"51","author":"KF Schaffner","year":"2001","unstructured":"Schaffner KF, McGorry PD (2001) Preventing severe mental illnesses\u2014new prospects and ethical challenges. Schizophr Res 51:3\u201315","journal-title":"Schizophr Res"},{"key":"2291_CR43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0006-3223(94)90076-0","volume":"36","author":"J Scherer","year":"1994","unstructured":"Scherer J, Tatsch K, Schwarz J, Oertel W, Kirsch MC, Albus M (1994) Striatal D2-dopamine receptor occupancy during treatment with typical and atypical neuroleptics. Biol Psychiatry 36:627\u2013629","journal-title":"Biol Psychiatry"},{"key":"2291_CR44","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jpsychires.2008.11.005","volume":"43","author":"AJ Schmidt","year":"2009","unstructured":"Schmidt AJ, Hemmeter UM, Krieg JC, Vedder H, Heiser P (2009) Impact of haloperidol and quetiapine on the expression of genes encoding antioxidant enzymes in human neuroblastoma SH-SY5Y cells. J Psychiatr Res 43:818\u2013823","journal-title":"J Psychiatr Res"},{"key":"2291_CR45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/0269881108096506","volume":"24","author":"AJ Schmidt","year":"2010","unstructured":"Schmidt AJ, Krieg JC, Clement HW, Hemmeter UM, Schulz E, Vedder H, Heiser P (2010) Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro. J Psychopharmacol 24:349\u2013354","journal-title":"J Psychopharmacol"},{"key":"2291_CR46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0893-133X(00)00096-8","volume":"23","author":"E Shadach","year":"2000","unstructured":"Shadach E, Gaisler I, Schiller D, Weiner I (2000) The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin. Neuropsychopharmacology 23:151\u2013161","journal-title":"Neuropsychopharmacology"},{"key":"2291_CR47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1023\/B:NEUR.0000011327.23739.1b","volume":"32","author":"SK Sharma","year":"2003","unstructured":"Sharma SK, Carlson EC, Ebadi M (2003) Neuroprotective actions of Selegiline in inhibiting 1-methyl, 4-phenyl, pyridinium ion (MPP+)-induced apoptosis in SK-N-SH neurons. J Neurocytol 32:329\u2013343","journal-title":"J Neurocytol"},{"key":"2291_CR48","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1097-4547(19970501)48:3<226::AID-JNR5>3.0.CO;2-H","volume":"48","author":"JP Sheehan","year":"1997","unstructured":"Sheehan JP, Palmer PE, Helm GA, Tuttle JB (1997) MPP+ induced apoptotic cell death in SH-SY5Y neuroblastoma cells: an electron microscope study. J Neurosci Res 48:226\u2013237","journal-title":"J Neurosci Res"},{"key":"2291_CR49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S1461145709990654","volume":"13","author":"V Singh","year":"2010","unstructured":"Singh V, Singh SP, Chan K (2010) Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia. Int J Neuropsychopharmacol 13:257\u2013271","journal-title":"Int J Neuropsychopharmacol"},{"key":"2291_CR50","first-page":"341","volume":"18","author":"X Song","year":"1997","unstructured":"Song X, Perkins S, Jortner BS, Ehrich M (1997) Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells. Neurotoxicology 18:341\u2013353","journal-title":"Neurotoxicology"},{"key":"2291_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.04.011","volume":"102","author":"R Tandon","year":"2008","unstructured":"Tandon R, Keshavan MS, Nasrallah HA (2008) Schizophrenia, \"just the facts\" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 102:1\u201318","journal-title":"Schizophr Res"},{"key":"2291_CR52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jnr.10281","volume":"69","author":"CG Wakade","year":"2002","unstructured":"Wakade CG, Mahadik SP, Waller JL, Chiu FC (2002) Atypical neuroleptics stimulate neurogenesis in adult rat brain. J Neurosci Res 69:72\u201379","journal-title":"J Neurosci Res"},{"key":"2291_CR53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S1461145704004390","volume":"7","author":"JS Wang","year":"2004","unstructured":"Wang JS, Ruan Y, Taylor RM, Donovan JL, Markowitz JS, Devane CL (2004) The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein. Int J Neuropsychopharmacol 7:415\u2013419","journal-title":"Int J Neuropsychopharmacol"},{"key":"2291_CR54","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jnr.20570","volume":"81","author":"H Wang","year":"2005","unstructured":"Wang H, Xu H, Dyck LE, Li X-M (2005) Olanzapine and quetiapine protect PC12 cells from beta-amyloid peptide(25-35)-induced oxidative stress and the ensuing apoptosis. J Neurosci Res 81:572\u2013580","journal-title":"J Neurosci Res"},{"key":"2291_CR55","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jnr.10668","volume":"73","author":"Z Wei","year":"2003","unstructured":"Wei Z, Bai O, Richardson JS, Mousseau DD, Li X-M (2003a) Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide. J Neurosci Res 73:364\u2013368","journal-title":"J Neurosci Res"},{"key":"2291_CR56","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/jnr.10832","volume":"74","author":"Z Wei","year":"2003","unstructured":"Wei Z, Mousseau DD, Richardson JS, Dyck LE, Li XM (2003b) Atypical antipsychotics attenuate neurotoxicity of beta-amyloid(25-35) by modulating Bax and Bcl-X(l\/s) expression and localization. J Neurosci Res 74:942\u2013947","journal-title":"J Neurosci Res"},{"key":"2291_CR57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0022-3956(97)00014-9","volume":"32","author":"RJ Wyatt","year":"1998","unstructured":"Wyatt RJ, Henter ID (1998) The effects of early and sustained intervention on the long-term morbidity of schizophrenia. J Psychiatr Res 32:169\u2013177","journal-title":"J Psychiatr Res"},{"key":"2291_CR58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jnr.10075","volume":"67","author":"XQ Xiao","year":"2002","unstructured":"Xiao XQ, Zhang HY, Tang XC (2002) Huperzine A attenuates amyloid beta-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation. J Neurosci Res 67:30\u201336","journal-title":"J Neurosci Res"},{"key":"2291_CR59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.freeradbiomed.2003.10.018","volume":"36","author":"H Zeng","year":"2004","unstructured":"Zeng H, Chen Q, Zhao B (2004) Genistein ameliorates beta-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis. Free Radic Biol Med 36:180\u2013188","journal-title":"Free Radic Biol Med"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-011-2291-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-011-2291-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-011-2291-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:12:23Z","timestamp":1558642343000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-011-2291-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,27]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["2291"],"URL":"https:\/\/doi.org\/10.1007\/s00213-011-2291-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,27]]}}}